NCT00471159View on ClinicalTrials.gov

A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2007

Conditions
Breast Neoplasms
Interventions
DRUG

docetaxel

DRUG

PF-3512676

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY